Hepatobilier Sistemin Değerlendirilmesinde Nükleer Tıp Görüntüleme Yöntemleri
Özet
Hepatobiliyer sistem hastalıklarının tanı ve takibinde nükleer tıp yöntemleri, fonksiyonel ve moleküler düzeyde kritik bilgiler sunmaktadır. Hepatobiliyer sintigrafi, özellikle akut/kronik kolesistit, biliyer atrezi ve safra kaçaklarının değerlendirilmesinde yüksek duyarlılığa sahip invaziv olmayan bir yöntemdir. Karaciğer fonksiyonlarını ve safra akış dinamiklerini gerçek zamanlı izleyerek anatomik detayların ötesinde fizyolojik veriler sağlar. FDG-PET/BT ve PET/MR ise hücresel glukoz metabolizmasını aydınlatarak primer karaciğer tümörleri, kolanjiokarsinomlar, safra kesesi kanserleri ve metastatik odakların saptanmasında önemli rol oynar. Bu ileri görüntüleme yöntemleri, lezyonların malign-benign ayrımının yapılmasına, doğru evrelemeye, tedaviye yanıtın izlenmesine ve prognoz tahminine olanak tanır. Tümör diferansiyasyonu ve intratümöral değişikliklere bağlı olarak FDG tutulum derecesi değişkenlik gösterse de, moleküler arka planın anlaşılması klinik stratejilerin belirlenmesinde ve cerrahi planlamada optimize edilmiş sonuçlar sağlar.
Nuclear medicine modalities offer critical functional and molecular insights for diagnosing and monitoring hepatobiliary system disorders. Hepatobiliary scintigraphy is a highly sensitive, non-invasive technique primarily utilized to evaluate acute/chronic cholecystitis, biliary atresia, and bile leaks. By monitoring liver function and bile flow dynamics in real time, it delivers vital physiological data beyond structural details. Concurrently, FDG-PET/CT and PET/MR imaging illuminate cellular glucose metabolism, playing a pivotal role in detecting primary liver malignancies, cholangiocarcinomas, gallbladder cancers, and metastatic lesions. These advanced diagnostic tools facilitate the differentiation between benign and malignant lesions, precise staging, treatment response evaluation, and prognostic assessments. Although FDG uptake intensity varies based on tumor differentiation and intratumoral alterations, understanding the underlying molecular mechanism significantly optimizes clinical strategy selection and pre-operative management.
Referanslar
Doonan M. Hepatobiliary Imaging. Journal of Nuclear Medicine Technology December 2020, 48 (4) 304-310; DOI: https://doi.org/10.2967/jnmt.120.257436)
Tulchinsky M. , Ciak B.W. , Delbeke D. et all. SNM Practice Guideline for Hepatobiliary Scintigraphy 4.0. Journal of Nuclear Medicine Technology December 2010, 38 (4) 210-218; DOI: https://doi.org/10.2967/jnmt.110.082289
Krishnamurthy S., Cerulli-Switzer J., Chapman N. et all. Comparison of Gallbladder Function Obtained with Regular CCK-8 and Pharmacy-Compounded CCK-8. J Nucl Med 2003; 44:499–504
Paul Rodrigue, Asif Fakhri and Andrew Baumgartner. Gallbladder Fossa Abscess Masquerading as Cholecystitis After Cholecystectomy. Journal of Nuclear Medicine Technology December 2015, 43 (4) 295-296; DOI:https://doi.org/10.2967/jnmt.115.155606
Hepatobiliary Scintigraphy in 2014 Harvey A. Ziessman, J Nucl Med 2014; 55:967–975 DOI: 10.2967/jnumed.113.131490
Tulchinsky M., Colletti P.M., Allen T.W. Hepatobiliary Scintigraphy in Acute Cholecystitis. Semin Nucl Med 42:84-100 © 2012 Elsevier Inc.
Naeem S. Precise Localization of a Bile Leak with Hepatobiliary Scintigraphy. J Nucl Med Technol. 2015;44:44.
Biloma: A Rare Manifestation of Spontaneous Bile Leak. Muhammad N Yousaf, Rowena G D'Souza,Fizah Chaudhary, Hamid Ehsan, and Charmian Sittambalam. Cureus. 2020 May; 12(5): e8116.
Noninvasive imaging of the biliary system relevant to percutaneous interventions. Thomas S, Jahangir K. Semin Intervent Radiol. 2016;33:277–282.
Serenari M., Bonatti C., Zanoni L, Peta G., Tabacchi E. et all. The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single‑center pilot study. Updates in Surgery (2021) 73:197–208 https://doi.org/10.1007/s13304-020-00907-2
Kumi Ozaki, Kenichi Harada, Noboru Terayama, Nobuyuki Kosaka, Hirohiko Kimura & Toshifumi Gabata FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular backgroundJapanese Journal of Radiology 38, 697–718 (2020)
Noy A, Schöder H, Gönen M, Weissler M, Ertelt K, Cohler C, et al. The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol. 2009;20(3):508–12.
Rodriguez M, Rehn S, Ahlström H, Sundström C, Glimelius B. Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J Nucl Med. 1995;36(10):1790–6.
Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, et al. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. J Clin Oncol. 2008;26(2):196–203.
Garin E, Le Jeune F, Devillers A, Cuggia M, de Lajarte-Thirouard AS, Bouriel C, et al. Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. J Nucl Med. 2009;50(6):858–64.
Yuekai Li, Fengcai Li, Xin Li, Lili Qu and Jiankui Han. Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary. Medicine (Baltimore). 2020 Dec 11; 99(50): e23210.Published online 2020 Dec 11. doi: 10.1097/MD.0000000000023210.
Nina Zhou, Xiangxi Meng,Yan Zhang, Boqi Yu, Jianmin Yuan, Jiangyuan Yu, Hua Zhu, and Zhi Yang. Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT Front Oncol. 2021; 11: 717687. Published online 2021 Aug 30. doi: 10.3389/fonc.2021.717687.
Kim NH., Lee SR, Kim YH, and Kim HJ. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.Korean J Radiol. 2020 Dec; 21(12): 1355–1366.
Parida, GK., Panda, RA., Agrawal K. Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis. Nuclear Medicine Communications, Volume 42, Number 8, 18 March 2021, pp. 846-854(9).
Leung U., Pandit-Taskar N., Corvera CU., D'Angelica MI, Allen PJ, Kingham TP. Impact of pre-operative positron emission tomography in gallbladder cancer. HPB (Oxford). 2014 Nov;16(11):1023-30. doi: 10.1111/hpb.12282. Epub 2014 Jun 4.
Ramos-Font C., Gómez-Rio M, Rodríguez-Fernández A., Jiménez-Heffernan A, Sánchez RS et all. Ability of FDG-PET/CT in the detection of gallbladder cancer.J Surg Oncol. 2014 Mar;109(3):218-24. doi: 10.1002/jso.23476. Epub 2013 Oct 25.
Lee JY., Kim HJ, Yim SH., Shin DS., Yu JH et all. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer. Korean J Gastroenterol. 2013 Oct;62(4):227-33. doi:10.4166/kjg.2013.62.4.227.
